10
Views
1
CrossRef citations to date
0
Altmetric
Letters

Continued Insensitivity to Conflicts of Interest at IARC

Pages 88-89 | Published online: 20 Nov 2013

References

  • Declaration of Interests for WHO experts. http://www.whoint/pcs/ra_site/docs/declaration_of_interest_copy(1).pdf.
  • Monograph Volume 84: Some drinking water disinfectants and contaminants, including arsenic.
  • About AWWA http://www.awwa.org.
  • About ILSI: http://www.ilsi.org/about/. ILSI Assembly of Members: http://pan.ilsi.org/about/assem-b1y_of_members.pdf.
  • Hansen ES. No effect or no informa-don? Comments on a nested case-con-trol study of lung cancer among Euro-pean rock and slag wool production workers. Int J Occup Environ Health. 2002; 8: 281–3.
  • Melnick RL. The IARC evaluation of di ( 2-ethylhexyl) phthalate (DEHP) : a flawed decision based on an untested hypothesis. lot J Occup Environ Health. 2002; 8: 284–6.
  • Sass J. Lead IARC towards compliance with WHO/IARC Declaration of Inter-ests (DOI) policy. Int J Occup Environ Health. 2002; 8: 277–8.
  • Huff J. IARC monographs, industry influence, and upgrading, downgrad-ing, and under-grading chemicals: a personal point of view. Int J Occup Env-iron Health. 2002; 8: 249–70.
  • Tomatis L. The IARC monographs pro-gram: changing attitudes towards public health. Int J Occup Environ Health. 2002; 8: 144–52.
  • Axelson O, Castleman B, Epstein S, et al. Re: Implementation of WHO Guide-lines on Disclosure of Interest by mem-bers of WHO Expert Panels. Int J Occup Environ Health. 2002; 8: 271–3.
  • Letter to J. Rice, IARC. from O. Tudor (TUC), S. Cappuccio (ITGLWF), R. Green (ICEM), F. Murie (IFBWW), R. O'Neill (IFJ), R. Oswald (IUF), S. Pen-nicuik (ACTU), P. Seminario (AFL-CIO). October 12, 2002. www.tuc.org.uk/h_and_s/tuc-5660-flicfm.
  • Global: Cancer in the system affects research agency. Risks. 75, 12 October 2002. http://www.tuc.org.uk/h_and_s/tuc-566140.cfrn#i4.
  • Burton A. Is industry influencing IARC to downgrade carcinogens? Lancet Oncol. 2003;4 (1): 4.
  • Transparency at IARC. Lancet. 2003; 361:189.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.